SYNTHETIC NEUROPROTECTIVE GLUTAMATE RELEASE BLOCKERS
合成神经保护谷氨酸释放阻滞剂
基本信息
- 批准号:2267723
- 负责人:
- 金额:$ 25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-12-17 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:NMDA receptors aminoacid inhibitor calcium channel calcium channel blockers cerebral ischemia /hypoxia chemical models chemical structure function chemical substitution conformation drug design /synthesis /production drug interactions drug screening /evaluation electrophysiology gerbil /jird glutamates guanidines laboratory rat molecular biology neuropharmacology neuroprotectants neurotransmitter transport sodium channel voltage /patch clamp voltage gated channel
项目摘要
Brain damage in stroke and in cardiac arrest results from an inadequate
supply of blood to the brain, termed brain ischemia. Brain ischemia
depletes the energy stores of affected brain regions and causes the
excessive release of glutamate and other neurotransmitters from
metabolically compromised nerve terminals. Our goal is to discover
synthetic, selective antagonists of the ion channels controlling the
release of glutamate and other neurotransmitters. Such compounds may be
employed as drugs to limit brain damage in focal ischemia (stroke) and
global ischemia (resulting from cardiac arrest or complications of
cardiac surgery). Using novel drug discovery methology based on a
proprietary method for monitoring neurotransmitter release from brain
nerve terminals, we have developed a novel compound series of synthetic
glutamate release blockers, members of which are highly neuroprotective
in an animal model of brain ischemia. During Phase II, we hope to
incorporate rational drug design strategies resulting from knowledge on
the structure of the site of interaction of these neuroprotective
compounds with its ion channel targets. Candidates for drug development
are likely to emerge from the Phase II project period, and selection of
such candidates is the central goal of the project.
中风和心脏骤停造成的脑损伤是由于缺乏
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES B FISCHER其他文献
JAMES B FISCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES B FISCHER', 18)}}的其他基金
DITOLYL GUANIDINE ANALOGS AS ANTIPSYCHOTIC DRUGS
作为抗精神病药的二甲苯基胍类似物
- 批准号:
3509014 - 财政年份:1989
- 资助金额:
$ 25万 - 项目类别:
DITOLYL GUANIDINE ANALOGS AS ANTIPSYCHOTIC DRUGS
作为抗精神病药的二甲苯基胍类似物
- 批准号:
3509013 - 财政年份:1989
- 资助金额:
$ 25万 - 项目类别:
DITOLYL GUANIDINE ANALOGS AS ANTIPSYCHOTIC DRUGS
作为抗精神病药的二甲苯基胍类似物
- 批准号:
3503199 - 财政年份:1989
- 资助金额:
$ 25万 - 项目类别:
SCREENING ASSAY FOR EXCITATORY AMINO ACID ANTAGONISTS
兴奋性氨基酸拮抗剂的筛选测定
- 批准号:
3504298 - 财政年份:1988
- 资助金额:
$ 25万 - 项目类别:














{{item.name}}会员




